Bellicum Pharmaceuticals, Inc (BLCM)

Etorro trading 970x250
Bellicum Pharmaceuticals, Inc (BLCM) Logo

About Bellicum Pharmaceuticals, Inc

Bellicum Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel cellular immunotherapies for the treatment of hematological cancers and solid tumors in the United States and internationally. The company’s clinical product candidates include BPX-601, an autologous GoCAR-T product candidate, which is in Phase 1/2 clinical trials for the treatment of solid tumors expressing the prostate stem cell antigen; and BPX-603, a dual-switch GoCAR-T product candidate that is in Phase 1/2 clinical trials to treat solid tumors that express the human epidermal growth factor receptor 2 antigens. It has collaboration and license agreements with Adaptimmune Therapeutics plc, Agensys, Inc., BioVec Pharma, Inc., ARIAD Pharmaceuticals, Inc., and Baylor College of Medicine. Bellicum Pharmaceuticals, Inc. was founded in 2004 and is headquartered in Houston, Texas. Address: 2710 Reed Road, Houston, TX, United States, 77051

Bellicum Pharmaceuticals, Inc News and around…

Latest news about Bellicum Pharmaceuticals, Inc (BLCM) common stock and company :

5 Value Stocks In The Healthcare Sector
06 Sep, 2021 FinancialContent

What Defines a Value Stock? A value stock traditionally has a lower price when compared to stock prices of companies in the same ...

Bellicum Pharmaceuticals to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference
03 Sep, 2021 FinancialContent
54 Biggest Movers From Yesterday
02 Sep, 2021 FinancialContent

Gainers Focus Universal Inc. (NASDAQ: FCUV) shares climbed 278% to close at $19.28 on Wednesday. The stock started trading on ...

38 Stocks Moving In Wednesday's Mid-Day Session
01 Sep, 2021 FinancialContent

Gainers Focus Universal Inc. (NASDAQ: FCUV) shares jumped 108.2% to $10.62. The stock started trading on Nasdaq Capital Market ...

Why Is Bellicum Stock Moving Higher On Wednesday?
01 Sep, 2021 FinancialContent

Bellicum Pharmaceuticals Inc(NASDAQ: BLCM) andThe University of Texas MD Anderson Cancer Centerhaveannounced ...

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
01 Sep, 2021 FinancialContent

Gainers GBS (NASDAQ:GBS) stock moved upwards by 51.23% to $4.9 during Wednesday's pre-market session. The market ...

Bellicum and MD Anderson Announce Additional License Agreement for Use of CaspaCIDe® Safety Switch
01 Sep, 2021 FinancialContent
12 Health Care Stocks Moving In Tuesday's After-Market Session
24 Aug, 2021 FinancialContent

Gainers Regencell Bioscience (NASDAQ:RGC) stock rose 51.24% to $23.14 during Tuesday's after-market session. Regencell Bioscience's ...

Bellicum Reports Second Quarter 2021 Financial Results and Provides Operational Update
12 Aug, 2021 FinancialContent
Bellicum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
26 Jul, 2021 FinancialContent
12 Health Care Stocks Moving In Monday's Pre-Market Session
19 Jul, 2021 FinancialContent

Gainers NRX Pharmaceuticals (NASDAQ:NRXP) stock moved upwards by 67.6% to $14.28 during Monday's pre-market session. ...

Bellicum Enters License Agreement with UNC Lineberger and Mass General for Use of CaspaCIDe® Safety Switch
28 Jun, 2021 FinancialContent
Should I Avoid Bellicum Pharmaceuticals Inc (BLCM)?
13 Jun, 2021 Yahoo! Finance

As we already know from media reports and hedge fund investor letters, hedge funds delivered their best returns in a decade. Most investors who decided to stick with hedge funds after a rough 2018 recouped their losses by the end of the fourth quarter of 2019. A significant number of hedge funds continued their strong […]

12 Health Care Stocks Moving In Wednesday's After-Market Session
09 Jun, 2021 FinancialContent

Gainers Enzo Biochem (NYSE:ENZ) stock increased by 8.49% to $3.45 during Wednesday's after-market session. Today's trading volume for ...

12 Health Care Stocks Moving In Wednesday's Intraday Session
26 May, 2021 FinancialContent

Gainers Owens & Minor (NYSE:OMI) shares rose 25.47% to $40.66 during Wednesday's regular session. As of 12:31 ...

The Daily Biotech Pulse: Pfizer-BioNTech COVID-19 Order Flow Abounds, Voyager CEO, CMO To Depart, Decision Day For Bristol-Myers Squibb, ASCO Abstracts Move Stocks
20 May, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

Bellicum Reports First Quarter 2021 Financial Results and Provides Operational Update
17 May, 2021 FinancialContent
31 Stocks Moving in Thursday's Pre-Market Session
01 Apr, 2021 FinancialContent

Gainers Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) rose 44.4% to $10.73 in pre-market trading after the company, and EMC Pharma, ...

The Daily Biotech Pulse: Pfizer Vaccine 100% Effective In Adolescents, Equillium Readout, Amgen Goes Shopping, Achilles IPO
31 Mar, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

12 Stocks Moving In Tuesday's After-Hours Session
30 Mar, 2021 FinancialContent

Gainers Equillium (NASDAQ: EQ) shares are trading higher after the company announced "favorable" topline data from the ...

Bellicum Reports Fourth Quarter 2020 Financial Results and Provides Operational Update
30 Mar, 2021 FinancialContent
Bellicum Pharmaceuticals, Inc. to Host Earnings Call
30 Mar, 2021 Yahoo! Finance

NEW YORK, NY / ACCESSWIRE / March 30, 2021 / Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on March 30, 2021 at 5:00 PM Eastern Time.

The Daily Biotech Pulse: Wave Life Sciences Pulls Plug On 2 Assets, Amarin's Vascepa Snags European Approval, Biocept Jumps On Earnings
30 Mar, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

Earnings Scheduled For March 30, 2021
30 Mar, 2021 FinancialContent

Companies Reporting Before The Bell • Academy Sports (NASDAQ:ASO) is likely to report quarterly earnings at $0.52 per ...

The Week Ahead In Biotech (March 28-April 3): Acadia's Dementia Drug Update, Clinical Readouts, Few Earnings In Holiday-Shortened Week
27 Mar, 2021 FinancialContent

Biotech stocks reversed course and ended lower in the week ended March 26, drawing inspiration from the broader market weakness. The ...

Bellicum to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate Update
23 Mar, 2021 FinancialContent

Management to host webcast and conference call on Tuesday, March 30, 2021 at 5 p.m. ET / 2 p.m. PT

Bellicum Shares Are Trading Higher On First Reported Positive Clinical Use Of iC9 Safety Switch
04 Mar, 2021 FinancialContent

Bellicum Pharmaceuticals Inc(NASDAQ:BLCM) has announced thepublication of a case reportusing the company's ...

12 Health Care Stocks Moving In Thursday's Pre-Market Session
04 Mar, 2021 FinancialContent

Gainers Bellicum Pharmaceuticals (NASDAQ:BLCM) stock rose 19.48% to $4.6 during Thursday's pre-market session. The ...

Bellicum Announces First Reported Use of CaspaCIDe® Safety Switch to Mitigate CAR-T Cell Toxicity
04 Mar, 2021 FinancialContent
12 Health Care Stocks Moving In Friday's After-Market Session
12 Feb, 2021 FinancialContent

Gainers Bellicum Pharmaceuticals (NASDAQ:BLCM) stock moved upwards by 3.91% to $6.9 during Friday's after-market session. ...

Bellicum Pharmaceuticals, Inc (BLCM) is a NASDAQ Common Stock listed in , ,

970x250